103 related articles for article (PubMed ID: 29397827)
41. Differentiating lymphoblastic lymphoma and Ewing's sarcoma: lymphocyte markers and gene rearrangement.
Ozdemirli M; Fanburg-Smith JC; Hartmann DP; Azumi N; Miettinen M
Mod Pathol; 2001 Nov; 14(11):1175-82. PubMed ID: 11706081
[TBL] [Abstract][Full Text] [Related]
42. [N-myc gene copies in children with neuroblastoma and its clinical significance].
Ma XL; Gong LP; Zhou CJ; Zhang DW; Jin M; Wang HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1447-51. PubMed ID: 23257451
[TBL] [Abstract][Full Text] [Related]
43. T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma.
Gualco G; Weiss LM; Barber GN; Bacchi CE
Hum Pathol; 2010 Sep; 41(9):1238-44. PubMed ID: 20382409
[TBL] [Abstract][Full Text] [Related]
44. Transformation of follicular lymphoma to precursor B-cell lymphoblastic lymphoma with c-myc gene rearrangement as a critical event.
Young KH; Xie Q; Zhou G; Eickhoff JC; Sanger WG; Aoun P; Chan WC
Am J Clin Pathol; 2008 Jan; 129(1):157-66. PubMed ID: 18089500
[TBL] [Abstract][Full Text] [Related]
45. [Small cell variant of peripheral T-cell lymphoma, not otherwise specified: a clinicopathologic and immunophenotypic analysis].
Li YL; Liu WP; Tang Y; Zhao S; Zuo Z; Yang YH; Yang QP; Luo TY
Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):323-8. PubMed ID: 19575875
[TBL] [Abstract][Full Text] [Related]
46. An unusual presentation of precursor T cell lymphoblastic leukemia/lymphoma with cholestatic jaundice: case report.
Patel KJ; Latif SU; de Calaca WM
J Hematol Oncol; 2009 Mar; 2():12. PubMed ID: 19284608
[TBL] [Abstract][Full Text] [Related]
47. [Clinicopathologic study of 40 cases of mediastinal tumours of haematopoietic and lymphoid tissues].
Chen DB; Wang Y; Song QJ; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):376-81. PubMed ID: 22932404
[TBL] [Abstract][Full Text] [Related]
48. [Cytokine in phenotypic analysis of leukemia/lymphoma: suppression of gene expression of myeloperoxidase by IFN-gamma and subset of AML M1 defined by CD45RO+/RA-, CD7(-), CD34(-) and non-inducible HLA-DR antigen].
Tatsumi E; Yoneda N; Kawano S; Yamaguchi N
Rinsho Byori; 1993 Apr; 41(4):377-83. PubMed ID: 7688832
[TBL] [Abstract][Full Text] [Related]
49. Precursor T-lymphoblastic lymphoma: Speedy diagnosis in FNA and effusion cytology by morphology, immunochemistry, and flow cytometry.
Bhaker P; Das A; Rajwanshi A; Gautam U; Trehan A; Bansal D; Varma N; Srinivasan R
Cancer Cytopathol; 2015 Sep; 123(9):557-65. PubMed ID: 26243719
[TBL] [Abstract][Full Text] [Related]
50. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.
Le Gouill S; Talmant P; Touzeau C; Moreau A; Garand R; Juge-Morineau N; Gaillard F; Gastinne T; Milpied N; Moreau P; Harousseau JL; Avet-Loiseau H
Haematologica; 2007 Oct; 92(10):1335-42. PubMed ID: 18024371
[TBL] [Abstract][Full Text] [Related]
51. [Clinicopathological Features and Prognostic Factors of DLBCL].
Lin JY; Zheng YB; He HM; Wang JS; Yang Y; Chen DG; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):779-783. PubMed ID: 29950219
[TBL] [Abstract][Full Text] [Related]
52. A population-based study of cellular markers in R-CHOP treated diffuse large B-cell lymphoma patients.
Abdulla M; Laszlo S; Triumf J; Hedström G; Berglund M; Enblad G; Amini RM
Acta Oncol; 2016; 55(9-10):1126-1131. PubMed ID: 27549735
[TBL] [Abstract][Full Text] [Related]
53. [Clinical significance of c-myc oncogene amplification in primary hepatocellular carcinoma by interphase fluorescence in situ hybridization].
Fang Y; Huang B; Liang Q; Li H; Huang C
Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):180-2. PubMed ID: 11866973
[TBL] [Abstract][Full Text] [Related]
54. [Expression and significance of hTERT, c-myc and Ki-67 in hepatocellular carcinoma].
Fang YW
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):338-40. PubMed ID: 19351506
[TBL] [Abstract][Full Text] [Related]
55. [Expression and clinical significance of Mcl-1 in T-cell non-Hodgkin's lymphoma].
Lin XB; Jiang WQ; Zhong XY; Luo RZ
Ai Zheng; 2007 Apr; 26(4):435-9. PubMed ID: 17430669
[TBL] [Abstract][Full Text] [Related]
56. MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC/BCL2 protein double-positive diffuse large B-cell lymphoma.
Wang XJ; Medeiros LJ; Lin P; Yin CC; Hu S; Thompson MA; Li S
Am J Surg Pathol; 2015 Sep; 39(9):1250-8. PubMed ID: 25828389
[TBL] [Abstract][Full Text] [Related]
57. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
Zhao F; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
[TBL] [Abstract][Full Text] [Related]
58. [HOX11L2 expression and its clinical significance in paraffin-embedded T-lymphoblastic lymphoma].
Pan Y; Li GD; Liu WP; Zhou Q; Zhang WY
Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):585-8. PubMed ID: 16532965
[TBL] [Abstract][Full Text] [Related]
59. Primary thyroid T-lymphoblastic lymphoma: a case report and review of the literature.
Chen C; Yang Y; Jin L; Dong L; Zhang X; Xiang Y
Int J Clin Exp Pathol; 2014; 7(1):443-50. PubMed ID: 24427370
[TBL] [Abstract][Full Text] [Related]
60. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
